NCT02266966View on ClinicalTrials.gov

Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Subject
Interventions
DRUG

F2695

DRUG

Placebo

Trial Locations (1)

Unknown

Centre d'Investigation Clinique (CIC), Toulouse

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT02266966 - Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter